A Study on M&A Performance in Chinese Pharmaceutical Listed Companies

被引:0
|
作者
Wang Xiaoyun [1 ]
Ge Sainan [1 ]
机构
[1] Shenyang Ligong Univ, Sch Econ & Management, Shenyang 110159, Peoples R China
关键词
Pharmaceutical industry; The performance of merger and acquisition; Factor analysis;
D O I
暂无
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
Taking twenty-four Chinese pharmaceutical listed companies which have experienced merger and acquisition in 2008 as samples, the paper establishes a system to evaluate merger and acquisition performance through factor analysis. After analyzing and comparing the performance of these twenty-four samples from 2007 to 2012, the paper demonstrates that the performance is increased firstly and then decreased after merger and acquisition. Yet up or down, the performance after merger and acquisition is better than before. Therefore, this paper draws a conclusion that merger and acquisition is benefit for improving the performance of Chinese pharmaceutical listed companies.
引用
收藏
页码:30 / 33
页数:4
相关论文
共 50 条
  • [31] Empirical Research on Factors Influencing the Performance of Cross-national M&A of Domestic Listed Companies
    Yu Pengyi
    Liu Na
    [J]. PROCEEDINGS OF THE SIXTH INTERNATIONAL SYMPOSIUM ON CORPORATE GOVERNANCE, 2011, : 335 - 341
  • [32] An Empirical Study of Chinese Manufacturing Listed Companies' Merger Performance
    Xu, Chao-Yang
    Wang, Chen-Chen
    Liu, Xiong-Fei
    [J]. PROCEEDINGS OF THE 2016 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE AND MANAGEMENT INNOVATION, 2016, 10 : 299 - 303
  • [33] Can digitalization facilitate cross-border M&A? Evidence from Chinese A-share listed companies
    Wang, Jiaxin
    Yuan, Xue
    Huang, Xiang
    Liu, Chengxin
    Zhang, Pengdong
    [J]. RESEARCH IN INTERNATIONAL BUSINESS AND FINANCE, 2024, 67
  • [34] The characteristic analysis of M&A's financing preference of Chinese-listed companies after Equity Ownership Reform
    Lei Hui
    Hao Yan-yan
    [J]. PROCEEDINGS OF THE 2007 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE AND ENGINEERING, FINANCE ANALYSIS SECTION, 2007, : 487 - 492
  • [35] Do M&A funds create value in Chinese listed firms?
    Huang, Ying Sophie
    Guo, Feng
    Ma, Lina
    [J]. PACIFIC-BASIN FINANCE JOURNAL, 2023, 79
  • [36] Study on the application of DEA on performance evaluation of Chinese listed port companies
    Yu, Shaoqiang
    Zhou, Dongsheng
    [J]. PROCEEDINGS OF THE 2006 INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE AND ENGINEERING, 2006, : 679 - 685
  • [37] Impact of Non-tradable Share Reform on the Performance of Listed Companies-An Empirical Study of Chinese Listed Companies
    Wang, ZhenYi
    Fang, XiaoHong
    Luan, Chuan Yong
    Sun, Fen
    [J]. EIGHTH WUHAN INTERNATIONAL CONFERENCE ON E-BUSINESS, VOLS I-III, 2009, : 2102 - 2111
  • [38] Reasons for M&A: A perspective from senior executives' rural experiences-Evidence from Chinese private listed companies
    Xiao, Xiaohong
    Peng, Jinxia
    He, Xiaogang
    [J]. INTERNATIONAL REVIEW OF FINANCIAL ANALYSIS, 2024, 93
  • [39] Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies
    Lopez-Toro, Alberto A.
    Sanchez-Teba, Eva Maria
    Benitez-Marquez, Maria Dolores
    Rodriguez-Fernandez, Mercedes
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (09)
  • [40] Capital Mobility, Corporate Governance and M&A Performance -An Empirical Research Based on A-share Listed Companies in China
    Xin, Shan
    Xie, Hong
    Jiang, Xiafei
    [J]. PROCEEDINGS OF THE 2018 2ND INTERNATIONAL CONFERENCE ON EDUCATION, ECONOMICS AND MANAGEMENT RESEARCH (ICEEMR 2018), 2018, 182 : 759 - 765